Papillary thyroid carcinoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
BRAF |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 10: | Line 10: | ||
| IHC = HBME-1 +ve, [[CK19]] +ve, Galectin-3 +ve, thyroglobulin +ve, TTF-1 +ve | | IHC = HBME-1 +ve, [[CK19]] +ve, Galectin-3 +ve, thyroglobulin +ve, TTF-1 +ve | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = BRAF mutation - commonly | ||
| IF = | | IF = | ||
| Gross = | | Gross = | ||
| Line 156: | Line 156: | ||
Images: | Images: | ||
===Papillary thyroid carcinoma cribriform-morular variant=== | ===Papillary thyroid carcinoma cribriform-morular variant=== | ||
| Line 265: | Line 262: | ||
===IHC=== | ===IHC=== | ||
Thyroid versus something else: | Thyroid versus something else: | ||
*Thyroglobulin +ve. | *Thyroglobulin +ve.<ref name=pmid23637102>{{Cite journal | last1 = Sathiyamoorthy | first1 = S. | last2 = Maleki | first2 = Z. | title = Cytomorphologic overlap of differentiated thyroid carcinoma and lung adenocarcinoma and diagnostic value of TTF-1 and TGB on cytologic material. | journal = Diagn Cytopathol | volume = 42 | issue = 1 | pages = 5-10 | month = Jan | year = 2014 | doi = 10.1002/dc.22997 | PMID = 23637102 }}</ref> | ||
*TTF-1 ([[thyroid transcription factor-1]]) +ve. | *TTF-1 ([[thyroid transcription factor-1]]) +ve. | ||
*CD15 +ve.{{fact}} | *CD15 +ve.{{fact}} | ||
| Line 275: | Line 272: | ||
===Molecular=== | ===Molecular=== | ||
* | *BRAF mutation.<ref name=pmid35670964>{{cite journal |authors=Lam AK |title=Papillary Thyroid Carcinoma: Current Position in Epidemiology, Genomics, and Classification |journal=Methods Mol Biol |volume=2534 |issue= |pages=1–15 |date=2022 |pmid=35670964 |doi=10.1007/978-1-0716-2505-7_1 |url=}}</ref> | ||
====Tabular summary==== | ====Tabular summary==== | ||